Copertina

Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Kei‐Ichiro Uemura, Akinobu Togo, Tasuku Hiroshige, Keisuke Ohta, Kosuke Ueda, Kiyoaki Nishihara, Makoto Nakiri, Shingo Hirashima, Tsukasa Igawa, Kei‐Ichiro Nakamura
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	The Prostate
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Diagnosis and management of neuroendocrine prostate cancer
di: Ivan de Kouchkovsky, et al.
Pubblicazione: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
di: Chia‐Ling Hsieh, et al.
Pubblicazione: (2024)

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
di: Takafumi Yanagisawa, et al.
Pubblicazione: (2024)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
di: Shingo Ashida, et al.
Pubblicazione: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
di: Eric V. Li, et al.
Pubblicazione: (2024)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
di: Zain Abedali, et al.
Pubblicazione: (2024)

Effects of long‐term desmopressin treatment for nocturia in older people
di: Hirofumi Kurose, et al.
Pubblicazione: (2024)

Comparative Effectiveness of First‐Line Treatments for Castration‐Resistant Prostate Cancer: A Large‐Scale Retrospective Study in Japan
di: Akihito Hashizume, et al.
Pubblicazione: (2025)

Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy
di: Shintaro Narita, et al.
Pubblicazione: (2024)

Other‐cause mortality in incidental prostate cancer
di: Francesco Di Bello, et al.
Pubblicazione: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
di: Pranav Prakash, et al.
Pubblicazione: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
di: Kamil Malshy, et al.
Pubblicazione: (2024)

Establishment and Characterization of Patient‐Derived Xenograft Organoids for Personalized Treatment of Castration‐Resistant Prostate Cancer
di: Takuro Sunada, et al.
Pubblicazione: (2026)

Analysis of three primary prostatic sarcoma cases and literature review
di: Yirui Wei, et al.
Pubblicazione: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
di: Tianwei Jia, et al.
Pubblicazione: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
di: Reyhane Karegar‐Niavol, et al.
Pubblicazione: (2024)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
di: Thomas Büttner, et al.
Pubblicazione: (2024)

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
di: Xiangbin Kong, et al.
Pubblicazione: (2024)

Investigation of pelvic floor influence on prostate displacement in image‐guided radiotherapy
di: Hongbo Chai, et al.
Pubblicazione: (2024)

Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate
di: Chinade Roper, et al.
Pubblicazione: (2024)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
di: Ruth Himmelsbach, et al.
Pubblicazione: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
di: Matteo Massanova, et al.
Pubblicazione: (2024)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
di: Fabian Falkenbach, et al.
Pubblicazione: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
di: Sean A. Fletcher, et al.
Pubblicazione: (2024)

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
di: Stephen Schmit, et al.
Pubblicazione: (2024)

Performance of large language models on benign prostatic hyperplasia frequently asked questions
di: YuNing Zhang, et al.
Pubblicazione: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
di: Shuhei Kamada, et al.
Pubblicazione: (2024)

Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer
di: Nicolas Martelin, et al.
Pubblicazione: (2024)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
di: Ghazi Alanazi, et al.
Pubblicazione: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
di: Eli Marie Grindedal, et al.
Pubblicazione: (2024)

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis
di: Pengfei Zhang, et al.
Pubblicazione: (2024)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
di: Michal Jirásko, et al.
Pubblicazione: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
di: Julián Córdoba Sánchez, et al.
Pubblicazione: (2024)

PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer
di: Philip Sutera, et al.
Pubblicazione: (2024)

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer
di: Hemal Semwal, et al.
Pubblicazione: (2024)

Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review
di: Ahmad Abid, et al.
Pubblicazione: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
di: Naz Chaudary, et al.
Pubblicazione: (2024)

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67
di: Fengnian Zhao, et al.
Pubblicazione: (2024)

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
di: Catherine H. Marshall, et al.
Pubblicazione: (2024)

Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer
di: Thomas Büttner, et al.
Pubblicazione: (2024)